Kathrin Strasser-Weippl

TL;DR: An overview of present control measures for breast cancer across China is presented, epidemiological and socioeconomic diversities and disparities in access to care for various subpopulations are described, and demographic differences between China and high-income countries, and also within geographical and socioeconomic regions of China are described.

TL;DR: The extension of treatment with an adjuvant aromatase inhibitor to 10 years resulted in significantly higher rates of disease-free survival and a lower incidence of contralateral breast cancer than those with placebo, but the rate of overall survival was not higher with the aromat enzyme inhibitor than with placebo.

TL;DR: In this article, the authors present the findings of their Cancer Commission and their recommendations to encourage Latin American stakeholders to redouble their efforts to address this increasing cancer burden and to prevent it from worsening and threatening their societies.

TL;DR: The overall state of health and cancer control in each country is described and additional specific issues for consideration are described: for China, access to care, contamination of the environment, and cancer fatalism and traditional medicine; for India, affordability of care, provision of adequate health personnel, and sociocultural barriers to cancer control.

TL;DR: Dietary flaxseed has the potential to reduce tumor growth in patients with newly diagnosed breast cancer.